Leptin and vascular smooth muscle cells.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current pharmaceutical design

• Publication date

  2014-01-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/13816128113199990022PMID 23688016
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of insulin resistance in endothelial dysfunction

  2013cited by this paper
• Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome.

  2013cited by this paper
• Is there NO help for leptin?

  2012cited by this paper
• Leptin promotes the mobilization of vascular progenitor cells and neovascularization by NOX2-mediated activation of MMP9.

  2012cited by this paper
• The role of perivascular adipose tissue in vascular smooth muscle cell growth

  2012cited by this paper
• Leptin and the regulation of endothelial function in physiological and pathological conditions

  2012cited by this paper
• Leptin promotes osteoblast differentiation and mineralization of primary cultures of vascular smooth muscle cells by inhibiting glycogen synthase kinase (GSK)-3β.

  2012cited by this paper
• Leptin Potentiates Endothelium-Dependent Relaxation by Inducing Endothelial Expression of Neuronal NO Synthase

  2012cited by this paper
• Anticontractile Effect of Perivascular Adipose Tissue and Leptin are Reduced in Hypertension

  2012cited by this paper
• Vascular smooth-muscle-cell activation: proteomics point of view.

  2011cited by this paper
• Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress.

  2011cited by this paper
• Leptin receptor signaling: pathways to leptin resistance.

  2011cited by this paper
• Insulin says NO to cardiovascular disease.

  2011cited by this paper
• Signalling pathways and vascular calcification.

  2011cited by this paper
• Obesity and leptin resistance: distinguishing cause from effect.

  2010cited by this paper
• Leptin-signaling pathways and leptin resistance.

  2010cited by this paper
• Leptin receptors

  2010cited by this paper
• Oxidative Stress and Vascular Smooth Muscle Cell Growth: A Mechanistic Linkage by Cyclophilin A

  2010cited by this paper
• Leptin Inhibits the Proliferation of Vascular Smooth Muscle Cells Induced by Angiotensin II through Nitric Oxide-Dependent Mechanisms

  2010cited by this paper
• Leptin-induced vascular smooth muscle cell proliferation via regulating cell cycle, activating ERK1/2 and NF-kappaB.

  2010cited by this paper
• Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells

  2010cited by this paper
• Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5'-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein.

  2009cited by this paper
• Rho-kinase is an important therapeutic target in cardiovascular medicine.

  2009cited by this paper
• Resistance to acute NO-mimetic and EDHF-mimetic effects of leptin in the metabolic syndrome.

  2009cited by this paper
• Recent advances in understanding leptin signaling and leptin resistance.

  2009cited by this paper
• Physiological Models of Leptin Resistance

  2009cited by this paper
• Effect of Leptin on Vascular Calcification in Apolipoprotein E–Deficient Mice

  2009cited by this paper
• The non-excitable smooth muscle: Calcium signaling and phenotypic switching during vascular disease

  2008cited by this paper
• Adipokines, insulin resistance, and coronary artery calcification.

  2008cited by this paper
• Leptin increases endothelin type A receptor levels in vascular smooth muscle cells.

  2008cited by this paper
• Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors

  2008cited by this paper
• Preventing restenosis after angioplasty: a multistage approach.

  2008cited by this paper
• Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.

  2008cited by this paper
• Endothelial nitric oxide (NO) and its pathophysiologic regulation.

  2008cited by this paper
• Transactivation of epidermal growth factor receptor in vascular and renal systems in rats with experimental hyperleptinemia: role in leptin-induced hypertension.

  2008cited by this paper
• The effects of stretch on vascular smooth muscle cell phenotype in vitro.

  2008cited by this paper
• Endothelin-1 actions on vascular smooth muscle cell functions as a target for the prevention of atherosclerosis.

  2008cited by this paper
• Leptin-induced endothelial dysfunction in obesity.

  2008cited by this paper
• Role of extracellular signal-regulated kinases (ERK) in leptin-induced hypertension.

  2008cited by this paper
• Regulation of vascular smooth muscle cell differentiation.

  2007cited by this paper
• Actin Cytoskeleton Dynamics Promotes Leptin-Induced Vascular Smooth Muscle Hypertrophy via RhoA/ROCK- and Phosphatidylinositol 3-Kinase/Protein Kinase B-Dependent Pathways

  2007cited by this paper
• Leptin stimulates endothelin-1 expression via extracellular signal-regulated kinase by epidermal growth factor receptor transactivation in rat aortic smooth muscle cells.

  2007cited by this paper
• Leptin inhibits cell growth of human vascular smooth muscle cells.

  2007cited by this paper
• The Emerging Role of Vascular Smooth Muscle Cell Apoptosis in Atherosclerosis and Plaque Stability

  2007cited by this paper
• The role of nitric oxide in the pathophysiology of intimal hyperplasia.

  2007cited by this paper
• The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism.

  2007cited by this paper
• VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE: The Vascular Biology of Calcification

  2007cited by this paper
• Molecular basis of the effects of mechanical stretch on vascular smooth muscle cells.

  2007cited by this paper
• Leptin Regulates Neointima Formation After Arterial Injury Through Mechanisms Independent of Blood Pressure and the Leptin Receptor/STAT3 Signaling Pathways Involved in Energy Balance

  2007cited by this paper
• Expression of the leptin receptor in different types of vascular lesions

  2007cited by this paper
• Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates.

  2006cited by this paper
• Role of leptin in blood pressure regulation and arterial hypertension

  2006cited by this paper
• Insulin activates hypoxia-inducible factor-1α in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling

  2006cited by this paper
• Leptin and atherosclerosis.

  2006cited by this paper
• Role of nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) in the regulation of blood pressure by leptin in lean and obese rats.

  2006cited by this paper
• Redox signaling in hypertension.

  2006cited by this paper
• Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase.

  2006cited by this paper
• The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats

  2006cited by this paper
• Intracellular signalling pathways activated by leptin.

  2006cited by this paper
• Leptin induces hypertrophy via p38 mitogen-activated protein kinase in rat vascular smooth muscle cells.

  2005cited by this paper
• Effect of hyperleptinemia on endothelial nitric oxide production.

  2005cited by this paper
• Leptin Induces Vascular Smooth Muscle Cell Hypertrophy through Angiotensin II- and Endothelin-1-Dependent Mechanisms and Mediates Stretch-Induced Hypertrophy

  2005cited by this paper
• Central actions of adipocyte hormones.

  2005cited by this paper
• Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II

  2005cited by this paper
• Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin.

  2005cited by this paper
• Leptin signaling.

  2004cited by this paper
• Serum leptin and myocardial infarction in hypertension

  2004cited by this paper
• Leptin, obesity and cardiovascular disease

  2004cited by this paper
• Leptin Promotes Vascular Remodeling and Neointimal Growth in Mice

  2004cited by this paper
• Leptin and the cardiovascular system.

  2004cited by this paper
• Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance

  2004cited by this paper
• Plasma leptin and prognosis in patients with established coronary atherosclerosis.

  2004cited by this paper
• Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension.

  2004cited by this paper
• Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes.

  2004cited by this paper
• Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction

  2004cited by this paper
• Cooperation Between Insulin and Leptin in the Modulation of Vascular Tone

  2003cited by this paper
• Neointimal Formation After Endovascular Arterial Injury Is Markedly Attenuated in db/db Mice

  2003cited by this paper
• Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

  2003cited by this paper
• Association of Insulin Resistance, Hyperleptinemia, and Impaired Nitric Oxide Release With In-Stent Restenosis in Patients Undergoing Coronary Stenting

  2003cited by this paper
• Redox‐dependent signalling by angiotensin II and vascular remodelling in hypertension

  2003cited by this paper
• High serum leptin is associated with attenuated coronary vasoreactivity.

  2003cited by this paper
• Metalloprotease-dependent ErbB ligand shedding in mediating EGFR transactivation and vascular remodelling.

  2003cited by this paper
• Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway.

  2002cited by this paper
• Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study.

  2002cited by this paper
• PKB binding proteins. Getting in on the Akt.

  2002cited by this paper
• Influence of Leptin on Arterial Distensibility: A Novel Link Between Obesity and Cardiovascular Disease?

  2002cited by this paper
• Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta.

  2002cited by this paper
• Leptin signalling.

  2002cited by this paper
• Leptin Enhances the Calcification of Vascular Cells: Artery Wall as a Target of Leptin

  2001cited by this paper
• Vascular smooth muscle growth: autocrine growth mechanisms.

  2001cited by this paper
• Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS)

  2001cited by this paper
• Plasma leptin is independently associated with the intima-media thickness of the common carotid artery

  2001cited by this paper
• Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease.

  2000cited by this paper
• Leptin induces direct vasodilation through distinct endothelial mechanisms.

  2000cited by this paper
• Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases.

  2000cited by this paper
• Prediction of coronary events with electron beam computed tomography.

  2000cited by this paper
• Regulation of inducible nitric oxide synthase gene expression in vascular smooth muscle cells.

  1999cited by this paper
• Pivotal role of nitric oxide in the control of blood pressure after leptin administration.

  1999cited by this paper
• Inducible nitric oxide synthase and vascular injury.

  1999cited by this paper
• Leptin is associated with increased risk of myocardial infarction

  1999cited by this paper

• SCD1 deficiency alters the perivascular secretory function of adipocytes and induces phenotypic changes in vascular smooth muscle cells.

  2025cites this paper
• Mechanisms through which laparoscopic sleeve gastrectomy mitigates atherosclerosis risk: a focus on visceral adipose tissue

  2025cites this paper
• Adipose Tissue‐Derived Adipokines in Vascular Physiology and Pathophysiology: Insights and Implications

  2025cites this paper
• Cellular and Molecular Mechanisms of VSMC Phenotypic Switching in Type 2 Diabetes

  2025cites this paper
• Unlocking the secrets: Adipose tissue dysfunction and atherosclerosis-mechanisms and innovative therapeutic approaches.

  2025cites this paper
• Renal denervation alleviates vascular remodeling in spontaneously hypertensive rats by regulating perivascular adipose tissue

  2024cites this paper
• Baroreflex afferent function is a part of insights of Leptin-mediated blood pressure reduction and Leptin-resistance hypertension.

  2024cites this paper
• Impact of Angiotensin Receptor Blockers on Angiotensin III and Leptin in Rabbits

  2023cites this paper
• The Effects of RBP4 and Vitamin D on the Proliferation and Migration of Vascular Smooth Muscle Cells via the JAK2/STAT3 Signaling Pathway

  2022cites this paper
• Senescent cells suppress innate smooth muscle cell repair functions in atherosclerosis

  2021cites this paper
• Ghrelin and adipokines: An overview of their physiological role, antimicrobial activity and impact on cardiovascular conditions.

  2021cites this paper
• Elevated retinol binding protein 4 levels are associated with atherosclerosis in diabetic rats via JAK2/STAT3 signaling pathway

  2021cites this paper
• Morphological and functional characteristics of retrosternal adipose tissue and their relation to arterial stiffness parameters in patients after coronary artery bypass grafting

  2020cites this paper
• PVAT targets VSMCs to regulate vascular remodelling: angel or demon

  2020cites this paper
• Design and comprehensive assessment of a biomimetic tri-layer tubular scaffold via biodegradable polymers for vascular tissue engineering applications.

  2020cites this paper
• Targeting perivascular and epicardial adipose tissue inflammation: therapeutic opportunities for cardiovascular disease.

  2020cites this paper
• The Effects of Leptin on the Proliferation and Differentiation of Primary Chondrocytes in Vitro and Cartilage Regeneration in Vivo.

  2019cites this paper
• [Daxx overexpression inhibits AngⅡ-induced proliferation and migration in vascular smooth muscle cells].

  2019cites this paper
• Exploring leptin from endothelial activation to subclinical organ damage in young black and white adults: the African-PREDICT study

  2019cites this paper
• Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease.

  2019cites this paper
• Identification of Potential Key Genes and Pathways in Early-Onset Colorectal Cancer Through Bioinformatics Analysis

  2019cites this paper
• Nesfatin-1 functions as a switch for phenotype transformation and proliferation of VSMCs in hypertensive vascular remodeling.

  2018cites this paper
• Paeoniflorin inhibits VSMCs proliferation and migration by arresting cell cycle and activating HO‐1 through MAPKs and NF‐&kgr;B pathway

  2018cites this paper
• Challenging the mystique Connection. Deciphering cell-matrix interactions role in atherosclerosis and restenosis.

  2017cites this paper
• Targeting white, brown and perivascular adipose tissue in atherosclerosis development

  2017cites this paper
• Egr-1 mediates leptin-induced PPARγ reduction and proliferation of pulmonary artery smooth muscle cells

  2017cites this paper
• Angiotensin-(1–7) abrogates angiotensin II-induced proliferation, migration and inflammation in VSMCs through inactivation of ROS-mediated PI3K/Akt and MAPK/ERK signaling pathways

  2016cites this paper
• High dietary fructose does not exacerbate the detrimental consequences of high fat diet on basilar artery function.

  2016cites this paper
• Adipokines, Vascular Wall, and Cardiovascular Disease

  2015cites this paper
• 20 years of leptin: Role of leptin in cardiomyocyte physiology and physiopathology.

  2015cites this paper
• 20 years of leptin: Role of leptin in cardiomyocyte physiology and physiopathology

  2015cites this paper
• MicroRNA-10b Induces Vascular Muscle Cell Proliferation Through Akt Pathway by Targeting TIP30.

  2015cites this paper
• Immune Mechanisms Linking Obesity and Preeclampsia

  2015cites this paper
• The correlation of serum levels of leptin, leptin receptor and NOx (NO2− and NO3−) in patients with obstructive sleep apnea syndrome

  2014cites this paper
• Interplay between phosphoinositide lipids and calcium signals at the leading edge of chemotaxing ameboid cells.

  2014cites this paper
• Differential effects of proteins and carbohydrates on postprandial blood pressure-related responses

  2014cites this paper
• Leptin and the cardiovascular system - a target for therapeutic interventions.

  2014cites this paper
• Metabolic Respiration Induces AMPK- and Ire1p-Dependent Activation of the p38-Type HOG MAPK Pathway

  2014cites this paper
• Molecular mechanism of (-)-epigallocatechin-3-gallate on balloon injury-induced neointimal formation and leptin expression.

  2014cites this paper
• Novel Molecular Aspects of Ghrelin and Leptin in the Control of Adipobiology and the Cardiovascular System

  2014cites this paper
• Expression of mammalian target of rapamycin in atherosclerotic plaques is decreased under diabetic conditions: a mechanism for rapamycin resistance.

  2014cites this paper
• 20 years of leptin : Role of leptin in cardiomyocyte physiology and physiopathology

  year unknowncites this paper